Poor medication timing, incorrect doses, medication disorganization, and under- or over-medication are some of the medication adherence issues that can occur in patients with MS and cognitive symptoms.
A significant unmet need remains for an effective, well-tolerated, and convenient treatment for patients with progressive forms of MS.
Application of technology developed in the gaming and computer control industry offers the opportunity to create new metrics with greater sensitivity and reproducibility.
Researchers aimed to determine the proportion of patients with early relapsing-remitting multiple sclerosis treated with natalizumab who achieve no evidence of disease activity at year 2.
Diabetes itself, complications of diabetes, or diabetes treatment may have protective effects on the risk of migraine.
Noninvasive vagus nerve stimulation may be able to fill a gap in the treatment of cluster headaches.
These results support further testing in larger phase 3 clinical trials.
Researchers examined whether there are clinical features or treatments associated with neuropsychiatric outcomes in BECTS.
This objective score may have the potential to be an early outpatient screening tool for identifying PNES.